Understanding the targeting of the RB family proteins by viral oncoproteins to defeat their oncogenic machinery

Journal of Cellular Physiology

Volumn 228, Issue 2, 2013, Pages 285-291

  Bellacchio, Emanuele ^a   Paggi, Marco G ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; E1A PROTEIN; ONCOPROTEIN; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; DNA VIRUS; EPSTEIN BARR VIRUS; MERKEL CELL POLYOMAVIRUS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; SEQUENCE ALIGNMENT; SIMIAN VIRUS 40; TRANSCRIPTION REGULATION; WART VIRUS;

AMINO ACID SEQUENCE; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; MERKEL CELL POLYOMAVIRUS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; RETINOBLASTOMA PROTEIN; TUMOR VIRUS INFECTIONS;

ADENOVIRIDAE; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; SIMIAN VIRUS 40;

EID: 84868031059     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24137     Document Type: Article

References (94)

1. Adams PD. 2001. Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 1471:M123-M133.
2. Adams PD, Li XT, Sellers WR, Baker KB, Leng XH, Harper JW, Taya Y, Kaelin WG, Jr. 1999. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol Cell Biol 19:1068-1080.
3. Berezutskaya E, Yu B, Morozov A, Raychaudhuri P, Bagchi S. 1997. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Cell Growth Differ 8:1277-1286.
4. Boyer SN, Wazer DE, Band V. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620-4624.
5. Brehm A, Kouzarides T. 1999. Retinoblastoma protein meets chromatin. Trends Biochem Sci 24:142-145.
6. Buchkovich K, Duffy LA, Harlow E. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
7. Burke JR, Deshong AJ, Pelton JG, Rubin SM. 2010. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem 285:16286-16293.
8. Campbell KS, Mullane KP, Aksoy IA, Stubdal H, Zalvide J, Pipas JM, Silver PA, Roberts TM, Schaffhausen BS, DeCaprio JA. 1997. DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication. Genes Dev 11:1098-1110.
9. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 89:4549-4553.
10. Chow KNB, Dean DC. 1996. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol Cell Biol 16:4862-4868.
11. Cobbs CS, Soroceanu L, Denham S, Zhang W, Kraus MH. 2008. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res 68:724-730.
12. Cobrinik D. 2005. Pocket proteins and cell cycle control. Oncogene 24:2796-2809.
13. DeCaprio JA. 1999. The role of the J domain of SV40 large T in cellular transformation. Biologicals 27:23-28.
14. DeCaprio JA, Ludlow JW, Figge J, Shew JY, Huang CM, Lee WH, Marsilio E, Paucha E, Livingston DM. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283.
15. DeCaprio JA, Furukawa Y, Ajchenbaum F, Griffin JD, Livingston DM. 1992. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci USA 89:1795-1798.
16. Dick FA, Dyson NJ. 2002. Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins. J Virol 76:6224-6234.
17. Dick FA, Dyson N. 2003. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol Cell 12:639-649.
18. Drew WL. 1991. Clinical use of ganciclovir for cytomegalovirus infection and the development of drug resistance. J Acquir Immune Defic Syndr 4:S42-S46.
19. Dyson N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262.
20. Fattaey AR, Harlow E, Helin K. 1993. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol Cell Biol 13:7267-7277.
21. Felsani A, Mileo AM, Paggi MG. 2006. Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25:5277-5285.
22. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100.
23. Fera D, Schultz DC, Hodawadekar S, Reichman M, Donover PS, Melvin J, Troutman S, Kissil JL, Huryn DM, Marmorstein R. 2012. Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins. Chem Biol 19:518-528.
24. Galderisi U, Jori FP, Giordano A. 2003. Cell cycle regulation and neural differentiation. Oncogene 22:5208-5219.
25. Gonzalez SL, Stremlau M, He X, Basile JR, Munger K. 2001. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J Virol 75:7583-7591.
26. Gonzalo S, Blasco MA. 2005. Role of Rb family in the epigenetic definition of chromatin. Cell Cycle 4:752-755.
27. Guo CP, Liu KW, Luo HB, Chen HB, Zheng Y, Sun SN, Zhang Q, Huang L. 2011. Potent anti-tumor effect generated by a novel human papillomavirus (HPV) antagonist peptide reactivating the pRb/E2F pathway. PLoS ONE 6:e17734.
28. Gustafsson B, Huang W, Bogdanovic G, Gauffin F, Nordgren A, Talekar G, Ornelles DA, Gooding LR. 2007. Adenovirus DNA is detected at increased frequency in Guthrie cards from children who develop acute lymphoblastic leukaemia. Br J Cancer 97:992-994.
29. Harbour JW, Dean DC. 2000. The Rb/E2F pathway: Expanding roles and emerging paradigms. Genes Dev 14:2393-2409.
30. Harris KF, Christensen JB, Radany EH, Imperiale MJ. 1998. Novel mechanisms of E2F induction by BK virus large-T antigen: Requirement of both the pRb-binding and the J domains. Mol Cell Biol 18:1746-1756.
31. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
32. Helt AM, Galloway DA. 2001. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J Virol 75:6737-6747.
33. Helt AM, Galloway DA. 2003. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24:159-169.
34. Henley SA, Francis SM, Demone J, Ainsworth P, Dick FA. 2010. A cancer derived mutation in the retinoblastoma gene with a distinct defect for LXCXE dependent interactions. Cancer Cell Int 10:8.
35. Hirschi A, Cecchini M, Steinhardt RC, Schamber MR, Dick FA, Rubin SM. 2010. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat Struct Mol Biol 17:1051-1057.
36. Honkaniemi E, Talekar G, Huang W, Bogdanovic G, Forestier E, von DU, Engvall M, Ornelles DA, Gooding LR, Gustafsson B. 2010. Adenovirus DNA in Guthrie cards from children who develop acute lymphoblastic leukaemia (ALL). Br J Cancer 102:796-798.
37. Hu QJ, Dyson N, Harlow E. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J 9:1147-1155.
38. Huang S, Wang NP, Tseng BY, Lee WH, Lee EH. 1990. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J 9:1815-1822.
39. Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF. 2008. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320:797-799.
40. Ikeda MA, Nevins JR. 1993. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol Cell Biol 13:7029-7035.
41. Jänicke RU, Walker PA, Lin XY, Porter AG. 1996. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 15:6969-6978.
42. Jones DL, Munger K. 1997. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol 71:2905-2912.
43. Kaelin WG, Jr., Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
44. Kalejta RF, Bechtel JT, Shenk T. 2003. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol 23:1885-1895.
45. Kelley WL, Georgopoulos C. 1997. The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone. Proc Natl Acad Sci USA 94:3679-3684.
46. Kim HY, Ahn BY, Cho Y. 2001. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen. EMBO J 20:295-304.
47. Knight JS, Sharma N, Robertson ES. 2005. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci USA 102:18562-18566.
48. Kuny CV, Chinchilla K, Culbertson MR, Kalejta RF. 2010. Cyclin-dependent kinase-like function is shared by the beta- and gamma-subset of the conserved herpesvirus protein kinases. PLoS Pathog 6:e1001092.
49. Lee C, Cho Y. 2002. Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor. Rev Med Virol 12:81-92.
50. Lee JO, Russo AA, Pavletich NP. 1998. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391:859-865.
51. Lee C, Chang JH, Lee HS, Cho Y. 2002. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev 16:3199-3212.
52. Lin JY, DeCaprio JA. 2003. SV40 large T antigen promotes dephosphorylation of p130. J Biol Chem 278:46482-46487.
53. Liu X, Marmorstein R. 2006. When viral oncoprotein meets tumor suppressor: A structural view. Genes Dev 20:2332-2337.
54. Liu X, Marmorstein R. 2007. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor. Genes Dev 21:2711-2716.
55. Liu X, Clements A, Zhao K, Marmorstein R. 2006. Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J Biol Chem 281:578-586.
56. Lowe ED, Tews I, Cheng KY, Brown NR, Gul S, Noble ME, Gamblin SJ, Johnson LN. 2002. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Biochemistry 41:15625-15634.
57. Ludlow JW, Shon J, Pipas JM, Livingston DM, DeCaprio JA. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387-396.
58. Ludlow JW, Glendening CL, Livingston DM, DeCaprio JA. 1993. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol 13:367-372.
59. Macaluso M, Montanari M, Giordano A. 2006. Rb family proteins as modulators of gene expression and new aspects regarding the interaction with chromatin remodeling enzymes. Oncogene 25:5263-5267.
60. Michaelis M, Paulus C, Loschmann N, Dauth S, Stange E, Doerr HW, Nevels M, Cinatl J, Jr. 2011. The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication. Cell Mol Life Sci 68:1079-1090.
61. Mihara K, Cao XR, Yen A, Chandler S, Driscoll B, Murphree AL, T'Ang A, Fung YK. 1989. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246:1300-1303.
62. Mittnacht S. 1998. Control of pRB phosphorylation. Curr Opin Genet Dev 8:21-27.
63. Morris EJ, Dyson NJ. 2001. Retinoblastoma protein partners. Adv Cancer Res 82:1-54.
64. Nevins JR. 1992. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
65. Paggi MG, Giordano A. 2001. Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother. Cancer Res 61:4651-4654.
66. Paggi MG, Baldi A, Bonetto F, Giordano A. 1996. Retinoblastoma protein family in cell cycle and cancer: A review. J Cell Biochem 62:418-430.
67. Patrick DR, Oliff A, Heimbrook DC. 1994. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. J Biol Chem 269:6842-6850.
68. Prichard MN, Sztul E, Daily SL, Perry AL, Frederick SL, Gill RB, Hartline CB, Streblow DN, Varnum SM, Smith RD, Kern ER. 2008. Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J Virol 82:5054-5067.
69. Qin XQ, Chittenden T, Livingston DM, Kaelin WG, Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6:953-964.
70. Raychaudhuri P, Bagchi S, Devoto SH, Kraus VB, Moran E, Nevins JR. 1991. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev 5:1200-1211.
71. Rubin SM, Gall AL, Zheng N, Pavletich NP, 2005. Structure of the Rb C-terminal domain bound to E2F1-D P1: A mechanism for phosphorylation-L induced E2F release. Cell 123:1093-1106.
72. Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES. 2011. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1. PLoS Pathog 7:e1001275.
73. Sawai ET, Butel JS. 1989. Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J Virol 63:3961-3973.
74. Schilling B, De-Medina T, Syken J, Vidal M, Munger K. 1998. A novel human DnaJ protein, hTid-1, a homolog of the Drosophila tumor suppressor protein Tid56, can interact with the human papillomavirus type 16 E7 oncoprotein. Virology 247:74-85.
75. Schulman BA, Lindstrom DL, Harlow E. 1998. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci USA 95:10453-10458.
76. Shirodkar S, Ewen ME, DeCaprio JA, Morgan J, Livingston DM, Chittenden T. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
77. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y. 2008. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 105:16272-16277.
78. Singh M, Krajewski M, Mikolajka A, Holak TA. 2005. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences. J Biol Chem 280:37868-37876.
79. Stubdal H, Zalvide J, Campbell KS, Schweitzer C, Roberts TM, DeCaprio JA. 1997. Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol Cell Biol 17:4979-4990.
80. Stubdal H, Zalvide J, DeCaprio JA. 1996. Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. J Virol 70:2781-2788.
81. Sullivan CS, Cantalupo P, Pipas JM. 2000a. The molecular chaperone activity of simian virus 40 large T antigen is required To disrupt Rb-E2F family complexes by an ATP-dependent mechanism [In Process Citation]. Mol Cell Biol 20:6233-6243.
82. Sullivan CS, Tremblay JD, Fewell SW, Lewis JA, Brodsky JL, Pipas JM. 2000b. Species-specific elements in the large T-antigen J domain are required for cellular transformation and DNA replication by simian virus 40 [In Process Citation]. Mol Cell Biol 20:5749-5757.
83. Trimarchi JM, Lees JA. 2002. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3:11-20.
84. Trofe J, Pote L, Wade E, Blumberg E, Bloom RD. 2008. Maribavir: A novel antiviral agent with activity against cytomegalovirus. Ann Pharmacother 42:1447-1457.
85. UniProt Consortium. 2012. Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res 40:D71-D75.
86. Vasconcelos GM, Kang M, Pombo-de-Oliveira MS, Schiffman JD, Lorey F, Buffler P, Wiemels JL. 2008. Adenovirus detection in Guthrie cards from paediatric leukaemia cases and controls. Br J Cancer 99:1668-1672.
87. Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegue E, Sage J. 2008. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 3:416-428.
88. Vietri M, Bianchi M, Ludlow JW, Mittnacht S, Villa-Moruzzi E. 2006 Direct interaction between the catalytic subunit of protein phosphatase 1 and pRb. Cancer Cell Int 6:3.
89. Williams CK, Vaithiyalingam S, Hammel M, Pipas J, Chazin WJ. 2012 Binding to retinoblastoma pocket domain does not alter the inter-domain flexibility of the J domain of SV40 large T antigen. Arch Biochem Biophys 518:111-118.
90. Xiao B, Spencer J, Clements A, Ali-Khan N, Mittnacht S, Broceno C, Burghammer M, Perrakis A, Marmorstein R, Gamblin SJ. 2003. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation. Proc Natl Acad Sci USA 100:2363-2368.
91. Zacksenhaus E, Bremner R, Phillips RA, Gallie BL. 1993. A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity. Mol Cell Biol 13:4588-4599.
92. Zalvide J, DeCaprio JA. 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen- mediated transformation. Mol Cell Biol 15:5800-5810.
93. Zalvide J, DeCaprio JA, Stubdal H. 2001. Binding of SV40 large T antigen to the retinoblastoma susceptibility gene product and related proteins. Methods Mol Biol 165:213-218.
94. Zalvide J, Stubdal H, DeCaprio JA. 1998. The J domain of Simian virus 40 large T antigen is required to functionally inactivate RB family proteins. Mol Cell Biol 18:1408-1415.